Illinois HR0100 urges Congress to pass legislation ensuring clinical drug trials reflect the intended patient population.
Illinois HR0100 urges Congress to pass legislation proposed by the Nu Paradigm Foundation. This legislation requires sponsors of clinical drug trials to include a diversity plan in their Investigational New Drug application. The plan must outline strategies to ensure trial participants reflect the intended patient population, including specific recruiting goals for underrepresented groups. The FDA would review this plan and may withhold drug approval if recruitment goals are not met.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.